SCHEMBL14083598

SCHEMBL14083598

O=C(Nc1cccc(Cl)c1Cl)c1ccc(-c2ncccc2Cl)cc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.52
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ TRPV1 Q8NER1 2/20 0.50
▸ SCN5A Q14524 2/20 0.48
▸ SCN9A Q15858 2/20 0.48
▸ PKM P14618 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ KDR P35968 1/20 0.46
▸ PABPC1 P11940 1/20 0.45
▸ EIF4H Q15056 1/20 0.45
▸ JAK2 O60674 1/20 0.44
▸ GRM4 Q14833 2/20 0.43
▸ PLEC Q15149 1/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083593 0.91 TRPV1 (0.52) MEN1KMT2ATRPV1SCN5ASCN9A
SCHEMBL14083621 0.90 RAB9A (0.53) MEN1KMT2ATRPV1SCN5ASCN9A
SCHEMBL14108062 0.88 HDAC1 (0.52) MEN1KMT2ATRPV1SCN5ASCN9A
SCHEMBL14083582 0.88 TRPV1 (0.49) GAAMEN1KMT2ATRPV1SCN5A
SCHEMBL14083597 0.85 GRM4 (0.50) MEN1KMT2ATRPV1NPC1RAB9A
SCHEMBL14083583 0.84 HDAC1 (0.51) MEN1KMT2ATRPV1SCN5ASCN9A
SCHEMBL14083587 0.84 ALDH1A1 (0.53) GAAMEN1KMT2ATRPV1MAPT
SCHEMBL14083572 0.84 TRPV1 (0.60) TRPV1GRM4
SCHEMBL14083586 0.83 CYP11B2 (0.55) MEN1KMT2ATRPV1NPC1RAB9A
SCHEMBL14083603 0.83 TRPV1 (0.46) MEN1KMT2ATRPV1SCN5ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 GAA 3059/4885MEN1 4218/4885KMT2A 4272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback